Addex Therapeutics Ltd

ADXNNASDAQHealthcare● Active

$5.86

+$0.00(+0.00%)

Market Cap$4220665

P/E Ratio—

52W High$12.05

52W Low$5.41

Avg Volume4K

Open$6.58

Beta1.97

SEC Filings

Foreign Private Issuer · Files 20-F / 6-K

Addex Therapeutics Ltd (ADXN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001574232 · ADXN · NASDAQ · as of Jun 9, 2026

Filing snapshot

260

Total Filings

6-K

Latest Form

2026-06-05

Most Recent

2020

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001574232 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY

Filed Date

2026-05-15

Fiscal Year End

May 15, 2026

Accession No.

0001104659-26-062447

Primary Document

adxn-20251231x20f.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001574232 · Accession 0001104659-26-062447

Latest Key Filings

6-KQuarterly Report

FORM 6-K

2026-06-05

View 6-K on SEC

8-KCurrent Report

No recent filings

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2026-06-05

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-003926

View

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-06-05

View

2026-05-15

20-F

Annual Report (Foreign Issuer)

FORM 20-F

0001104659-26-062447

View

20-FAnnual Report (Foreign Issuer)

FORM 20-F

2026-05-15

View

2026-04-30

NT 20-F

0001104659-26-052854

View

NT 20-FNT 20-F

NT 20-F

2026-04-30

View

2026-04-30

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-002871

View

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-04-30

View

2026-04-29

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-002787

View

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-04-29

View

2026-04-23

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-002661

View

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-04-23

View

2026-04-21

6-K

Current Report (Foreign Issuer)

FORM 6-K

0001171843-26-002589

View

6-KCurrent Report (Foreign Issuer)

FORM 6-K

2026-04-21

View

2026-03-25

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-034503

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-25

View

2026-03-25

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-034501

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-25

View

2026-03-25

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-034498

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-25

View

2026-03-25

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-034495

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-25

View

2026-03-25

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-034491

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-25

View

2026-03-18

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-030243

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-18

View

2026-03-18

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-030242

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-18

View

2026-03-18

Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

0001104659-26-030240

View

3Initial Statement of Beneficial Ownership

OWNERSHIP DOCUMENT

2026-03-18

View

Showing 1–15 of 260 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001574232 | Exchange: NASDAQ · Healthcare

Addex Therapeutics Ltd (NASDAQ: ADXN) has submitted 260 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001574232, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Addex Therapeutics Ltd's most comprehensive regulatory disclosure. The most recent Addex Therapeutics Ltd 10-K was filed on 2026-05-15 for fiscal year ending 2026. Historical ADXN 10-K annual reports are available from 2019 through 2026.

Investors researching Addex Therapeutics Ltd SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Related Companies SEC Filings — Healthcare

NBY SEC Filings →NRSN SEC Filings →BCLI SEC Filings →IBO SEC Filings →RADX SEC Filings →TCRT SEC Filings →MTNB SEC Filings →CDIO SEC Filings →

→ ADXN Financials → ADXN Earnings → ADXN Insider Trades

Frequently Asked Questions

ADXN SEC Filings · 8 questions

Addex Therapeutics Ltd (ADXN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 260 filings and access original documents at no cost. Addex Therapeutics Ltd's CIK is 0001574232.

ADXN SEC filingsAddex Therapeutics Ltd SEC documentsfind ADXN 10-K